29 January 2021 - Deborah Wilkes
Premium
Worldwide sales at Johnson & Johnson’s (J&J’s) OTC business declined in the fourth quarter of 2020 as measures to control the COVID-19 pandemic meant fewer people suffered from coughs, colds and flu.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.